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A child with maple syrup urine disease type 2 (MSUD2) was found to be homozygous for a 10-bp MSUD2-gene
deletion on chromosome 1. Both purported parents were tested, and neither carries the gene deletion. Polymorphic
simple-sequence repeat analyses at 15 loci on chromosome 1 and at 16 loci on other chromosomes confirmed
parentage and revealed that a de novo mutation prior to maternal meiosis I, followed by nondisjunction in maternal
meiosis II, resulted in an oocyte with two copies of the de novo mutant allele. Fertilization by a sperm that did
not carry a paternal chromosome 1 or subsequent mitotic loss of the paternal chromosome 1 resulted in the
propositus inheriting two mutant MSUD2 alleles on two maternal number 1 chromosomes.
Maple syrup urine disease is caused by homozygous mu-
tations, at one of four gene loci, that result in accumu-
lation of keto acids in the urine; it occurs at a frequency
of ∼1/224,000 newborns (Naylor and Guthrie 1982).
Each of these four genes encodes one of the subunits of
branched-chain keto acid dehydrogenase (Heffelfinger et
al. 1983). Mutations of both alleles at the same locus
result in MSUD1A (MIM 248600), MSUD1B (MIM
248611), MSUD2 (MIM 248610), or MSUD3.
In exceptional cases, autosomal recessive genetic dis-
ease results when an embryo inherits two otherwise nor-
mal chromosomes carrying a mutant gene from the only
carrier parent and inherits no chromosome of this type
from the parent with normal genes. Rare affected in-
dividuals have been reported with (a) one molecularly
characterized parent who is a carrier of either cystic fi-
brosis or abetalipoproteinemia (Beaudet et al. 1991;
Yang et al. 1999), (b) uniparental disomy (UPD) and
biochemically characterized cystic fibrosis and cystinosis
(Smith et al. 1991), or (c) UPD and a phenotype of
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Bloom syndrome or Chediak-Higashi syndrome (Wood-
age et al. 1994; Dufourcq-Lagelouse et al. 1999).
UPD of imprinted gene loci from the same parent re-
sults in genetic disease much more frequently than does
UPDwith a mutant gene. Fertilization between a disomic
gamete and a gamete monosomic for the same chro-
mosome, followed by loss of the normally inherited
chromosome (trisomic rescue), is considered to be the
more frequent mechanism of UPD formation, with a
3:1 preponderance of maternal UPD (Antonarakis et al.
1992). Imprinted genes have been reported to result in
human genetic disease when either both chromosomes
2, 7, 14, 15, or 16 are inherited from the mother or
both chromosomes 6, 11, 14, 15, or 20 are inherited
from the father (Falls et al. 1999).
DNA was extracted, according to the Puregene DNA
Isolation Kit protocol (Gentra Systems), from 6 ml of
whole blood, by doubling all recommended volumes and
excluding RNase treatment. The 20-pmol PCR-ampli-
fication primers uniquely amplified target sequences in
25–50 ng of genomic DNA in 20 mM Tris-HCl (pH
8.4), 50 mM KCl, 1.56 mM MgCl2, 0.208 mM of each
dNTP, 1 mCi of [32P]-dCTP, and 1 U of Taq polymerase
(Gibco BRL), in 12 ml. PCR proceeded by denaturing at
94C for 5 min, then denaturing at 94C for 30 s, an-
nealing at 55C for 30 s, and elongating at 72C for 30
s, for each of 30 cycles. The last cycle was completed





Mother (I-1) Propositus (II-1) Father (I-2)
D1S1612 114, 98 114, 114 130, 102
D2S1326 248, 240 240, 236 252, 236
D3S1286 147, 143 143, 133 143, 133
D3S2427 233, 225 235, 225 235, 225
D5S112 114, 98 106, 98 106, 98
D5S346 114, 106 114, 114 126, 114
D6S1056 240, 252 268, 240 268, 256
D8S1132 144, 140 148, 140 148, 144
D9S15 208, 200 200, 200 208, 200
D10S1237 412, 404 424, 404 424, 408
D12S391 229, 218 241, 229 241, 222
D13S137a 122, 113 128, 122 128, 113
D13S128a 170, 160 166, 160 166, 160
D15S643 211, 205 211, 205 215, 211
D16S539 162, 162 162, 158 162, 158
D20S470 310, 298 310, 298 310, 302
Selected UPD results:
D1S1612b (42.7 cMc) 114, 98 114, 114 130, 102
D1S1597b (51.2 cMc) 172, 164 164, 164 176, 172
D1S1598e (89.4 cMc) 119, 111 119, 111 119, 115
D1S1643e (124.1 cMc) 251, 251 251, 251 270, 266
MSUD2b Normal/Normal D10 bp/D10 bp Normal/Normal
D1S1655b (229.1 cMc) 196, 188 188, 188 205, 185
D1S1642b (262.7 cMc) 264, 260 264, 264 270, 257
D1S1617b (323.9 cMc) 135, 133 133, 133 123, 123
D1S1594b (338.4 cMc) 125, 121 125, 125 121, 117
a Both D13S137 and D13S128 were at Wilson disease gene locus; D13S137 was used in
calculation.
b Maternal UPD for one chromosome.
c Cooperative Human Linkage Center linkage-map distance.
d Maternal UPD for both chromosomes.
e Confirms maternal UPD for one or both chromosomes.
were resolved by 6% polyacrylamide gel electrophoresis
using an M13 sequencing ladder as a size marker. Elec-
trophoresed gels were dried on Whatman 3MM filter
paper and were autoradiographed at 80C.
Both E2 genes sequenced from a male child with
MSUD had a 10-bp deletion IVS10del(9;1), which
results in a 21-bp deletion in the processed mutant E2
mRNA (Chuang et al. 1999). Homozygous MSUD2 al-
leles on chromosome band 1p31 explained this child’s
clinical phenotype and suggested that the parents share
a common ancestor carrying the same rare allele. In ad-
dition to an affected son, this couple also had a normal
daughter and a third pregnancy that ended in sponta-
neous abortion. They were seen by us during the fourth
pregnancy because they already had borne a child with
MSUD2 and because they were of advanced age. Pre-
natal testing did not find the previously characterized
MSUD2mutation either in the current fetal DNA sample
or previously stored maternal and paternal lymphocyte
DNAs. Analysis of additional blood samples from both
parents and the propositus confirmed that the propositus
is homozygous for the MSUD2-gene deletion and that
neither purported parent is a carrier. As expected, the
mother delivered another normal baby.
Because these results could be explained by either non-
parentage or a rare genetic mechanism, a parentage test
was ordered for the propositus. The propositus shares
alleles with the purported mother, at all of 16 indepen-
dently segregating simple sequence repeat (SSR) poly-
morphic loci initially tested (table 1). With the allele
frequencies derived either from public databases or from
our accumulated database, the likelihood that I-1 is the
mother of II-1 was calculated to be 1,373:1 (data not
shown). At the same time, the purported father of II-1
shares with the propositus paternally derived alleles at
15 of 16 tested loci but does not share an allele at the
D1S1612 locus (fig. 1A and table 1). Although the pro-
positus is homozygous for a maternally derived 114-bp
D1S1612 allele, the father’s 102- and 130-bp alleles dif-
fer from the child’s 114-bp allele, by three and four
tetranucleotide repeats, respectively. The likelihood of
an allele changing a single repeat during meiosis is ∼1/
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Figure 1 Polymorphic results at three chromosome 1 loci. A
and B, Propositus, homozygous for one of the two maternal alleles at
the D1S1612 and D1S1655 loci. C, Results at the D1S1598 locus, the
single tested chromosome 1 locus in the propositus that is heterozygous
for two different length maternal alleles (111 and 119 bp).
Table 2








D1S551 .5 [f(180)]p .46 1.09:1
D1S540 1.0 [f(156)]p .056 17.9:1
D1S1623 1.0 [f(268)]p .071 14.1:1
D1S1642 .5 [f(264)]p .402 1.24:1
D1S1667 1.0 [f(218)]p .031 32.3:1
D1S1617 1.0 [f(133)]p .142 7.04:1
D1S1594 .5 [f(125)]p .069 7.25:1
D1S1597 .5 [f(164)]p .098 5.10:1
D1S1598 .5 [f(118 112)]p .32 .54 .58:1
D1S1661 1.0 [f(95)]p .233 4.29:1
D1S1648 .5 [f(186)]p .75 .67:1
Overall 4,750,605:1
1,000 (Weber and Wong 1993); the likelihood of chang-
ing two SSR repeats is on the order of 1/10,000; and
we have not found a three-tetranucleotide-repeat change
reported. Nevertheless, the purported father II-1 shared
paternally derived alleles at all 15 of 15 other tested loci.
The possibility of UPD for chromosome 1 was tested
because the D1S1612 locus is in the same region of the
chromosome-1 short arm as the MSUD2 locus and the
propositus is homozygous for a previously unreported
MSUD2 allele with a 10-bp deletion. SSR polymorphic
sites were analyzed in the propositus and his purported
parents at 15 loci spanning chromosome 1 from 32.7 to
338.3 cM along the Cooperative Human Linkage Center
chromosome-1 linkage map. All of the propositus’s
chromosome-1 polymorphic fragments could have been
inherited from his mother. The results at each locus were
considered to be independent events, because each is
sufficiently distant from the next locus. On the basis of
only the allele frequencies available in the CHLC da-
tabase at 11 of the 15 additional tested chromosome-1
loci, the calculated likelihood that the purported mother
is the mother is 4,750,605:1 (tables 1 and 2). When
multiplied by the likelihood of 1373:1 that this woman
is the mother, based on the other autosomal loci tested,
the combined posterior likelihood the propositus II-1 is
the child of purported mother I-2 is 1 .96# 10 :1
In contrast, the propositus did not share paternally
derived alleles at 7 of the 16 tested chromosome-1 loci
(table 1). However, the propositus II-1 is homozygous
at 15 of the 16 loci tested on chromosome 1, and all
alleles at all 16 loci of the child are carried by the mother
(table 1). Taken together, these results demonstrate ma-
ternal UPD of chromosome 1. This conclusion is further
supported by the fact that the MSUD2 locus is on chro-
mosome 1 and that the propositus has the same unique
mutation on both alleles (fig. 2 and table 1). Under the
assumption that maternity and maternal UPD of chro-
mosome 1 have been demonstrated, the likelihood that
the purported father is the father, based on the 15 au-
tosomal loci tested that are not on chromosome 1, ex-
ceeds . We conclude that the purported par-92# 10 :1
ents are the parents of the propositus.
The genetic mechanism resulting in maternal chro-
mosome-1 UPD can be derived from the chromosome-
1 SSR results (table 1). The propositus, II-1, is homo-
zygous for maternally derived alleles at 15 of 16 tested
chromosome-1 loci, consistent with maternal UPD from
a single grandparental chromosome 1. In contrast, the
fetus carried two different-length maternal alleles (118
and 112 bp) at locus D1S1598, derived from both grand-
parental chromosomes (fig. 1C and table 1). These re-
sults indicate that nondisjunction occurred in maternal
meiosis II, so that the centromeres of the same two
grandparental chromatids that had duplicated in the pre-
vious S-phase segregated into the oocyte prior to fertil-
ization. The single exception, at the D1S1598 locus dis-
tal to the MSUD2 locus, carries two different maternally
derived alleles resulting from one of two mechanisms:
(1) a double recombination in a single chromatid with
the breakpoints on either side of the D1S1598 locus
prior to meiosis I (fig. 3A) or (2) two single recombi-
nations, one proximal to D1S1598 in the first chromatid
and the second distal to D1S1598 in the second chro-
matid (fig. 3B). Thus, the propositus carries both ma-
ternal D1S1598 alleles (fig. 1C and table 1). Since the
MSUD2 locus is proximal to the heterozygous locus
D1S1598 and the homozygous loci D1S1661 and
D1S1643 on chromosome 1p (fig. 2 and table 1), the
MSUD2 locus is also homozygous and carries two copies
of the same mutant allele.
Because the MSUD2 mutation event occurred prior to
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Figure 2 Chromosome 1 ideogram, with PCR-amplified loca-
tions. The approximate locations of the PCR-amplified chromosome
1 sites are based on locations and recombination distances in The
Genome Database.
Figure 3 Meiotic recombination between homologous number
1 chromosomes. A, Double recombination on a single short arm of
both homologous chromatids, resulting in a recombinant chromosome
that is homozygous at three locations (aa, cc, and dd) and heterozygous
at one location (bb′). Maternal nondisjunction in meiosis II would
transmit both A-III chromatids to the oocyte. B, Single recombination
on each chromatid, also resulting in a recombinant chromosome that
is homozygous at three locations (a′a′, cc, and d,d) and heterozygous
at one location (bb′). The homozygous “a” locus differs, depending
on the recombination sites. These two possibilities cannot be distin-
guished without testing the grandparental DNAs, which were
unavailable.
maternal meiosis, this cell may have given rise to a large
proportion of gametes in one maternal gonad. The pro-
portion of carrier germline cells contributes little to this
couple’s risk for a child with MSUD2, because nondis-
junction of the mutation-carrying chromosome 1 in ma-
ternal meiosis II, selection for the abnormal genes in the
subsequent oocyte, and loss of the paternal chromosome
shortly after fertilization would all be required in order
to produce another viable fetus with the same genotype.
Therefore, this couple has a very low risk for a second
fetus with homozygous MSUD2. In contrast, if all germ-
line cells carry the MSUD2 mutation in one ovary of I-
2, the likelihood that another fetus of II-1 being a carrier
of the MSUD2 mutation is 25%. Given the typical fre-
quency of germline cells carrying new mutations in stud-
ies of germinal mosaic male mice, the likelihood of a
germinal mosaic transmitting another MSUD2mutation
would be in the range of 0.5%–6%. Nevertheless, this
couple has been offered MSUD2 testing for all future
pregnancies.
These results indicate that MSUD2 in the propositus
arose from two extremely rare events: (1) a de novo
mutation prior to S-phase of meiosis I in oogenesis and
(2) maternal UPD resulting from maternal nondisjunc-
tion in meiosis II. The likelihood of a deleterious mu-
tation occurring in a diploid human genotype has been
estimated to be 1.6 per generation (Eyre-Walker and
Keightley 1999). Although the frequency of UPD varies
for different chromosomes, the frequency of UPD for
chromosome 15 has been reported for both Prader-Willi
syndrome (25% of 1/10,000 newborns) and Angelman
syndrome (2% of 1/10,000 newborns; Amos-Landgraf
et al. 1999). Therefore, the frequency of chromosome
15 UPD is anticipated to be 1/37,000 newborns. When
the same frequency of UPD is used for chromosome 1,
the frequency of de novo MSUD at any one of the
four MSUD gene loci would be in the range of (1.6
mutations/diploid genome/generation) # (1 diploid ge-
nome/200,000 genes) # (4 MSUD genes) # (1 UPD
chromosome 1/37,000 newborns) p (1 newborn with
MSUD from de novo new mutation and UPD/
1,156,250,000 newborns).
Given that the frequency of all four forms of MSUD
is 1/224,000 newborns (Naylor and Guthrie 1982) and
that the frequency is the same for all types, the MSUD
carrier frequency can be calculated to be ∼1/118—
that is, [(1/473)2  (1/473)2( 1/473)2  (1/473)2](1/4)
p 1/224,000. When a UPD frequency of 1/37,000 new-
borns is assumed, the predicted frequency of MSUD
from chromosome 1 UPD transmitted by a carrier parent
would be newborns.1/118# 1/37,000p 1/4,366,000
These frequencies predict that de novo mutation and
UPD resulting in a genetic disease occurs much more
rarely than the previously reported cases of UPD and
genetic disease from a carrier parent.
In the case reported here, the three- and four-tetra-
nucleotide-repeat difference between paternal and pro-
positus allelic lengths at the D1S1612 locus suggest that
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the likelihood of paternity is much less than that which
would be expected on the basis of a single meiotic SSR
change. At the same time, paternity would have been
proved readily had only autosomal loci that were not
syntenic to the MSUD2 locus on chromosome 1 been
tested initially. This suggests that the optimal strategy in
testing parentage of a propositus with an autosomal re-
cessive genetic disease not carried by the purported par-
ents is to test only loci on chromosomes that do not
carry genes that, when mutated, would result in the pro-
positus’s genetic disease. Once parentage has been
proved, subsequent UPD testing of the pertinent chro-
mosome carrying a gene in which mutations result in
the propositus’s genetic disease is likely to be positive.
This would be important in localizing the mutant-gene
search, such as in the case of MSUD resulting from any
one of four gene loci.
A decrease in recombination has been reported in
demonstrated cases of UPD (Warren et al. 1987). In our
case, the propositus carries two different maternal poly-
morphic alleles at the D1S1598 locus, as a result of two
meiotic recombinations in a 295.7-cM genetic region
between the D1S1612 and D1S1594 loci, where ap-
proximately six recombinations are predicted. This con-
comitant decrease in recombination may be related to
the nondisjunction resulting in UPD.
In cases with rare genetic events, initial molecular ge-
netic–testing results may inaccurately suggest nonpar-
entage or reveal different relationships among individ-
uals in the pedigree. After unusual molecular test results
have been confirmed, most diagnoses, along with the
reliability and recurrence risks, can be reported without
addressing a newly discovered relationship. Occasion-
ally, one individual in the pedigree needs to be consulted
prior to communicating the molecular diagnosis. In these
cases, effective counseling needs to proceed with care,
judgment, understanding, and prudence.
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